INTE TERIM R RESU SULTS TS For the the S Six M Mont nths e - - PowerPoint PPT Presentation

inte terim r resu sults ts
SMART_READER_LITE
LIVE PREVIEW

INTE TERIM R RESU SULTS TS For the the S Six M Mont nths e - - PowerPoint PPT Presentation

INTE TERIM R RESU SULTS TS For the the S Six M Mont nths e end nded 30 30 September 2019 2019 Highlights FY2019 H1 FY2020 H1 Change FY2020 H1 excl. IFRS reported reported 16 impact Net sales (million ) 595.4 727.2 +22.1%


slide-1
SLIDE 1

INTE TERIM R RESU SULTS TS

For the the S Six M Mont nths e end nded 30 30 September 2019 2019

slide-2
SLIDE 2

Highlights

2

* The Group adopted IFRS 16 from 1 April 2019 but has not restated comparatives for the prior year’s reporting period.

FY2019 H1 FY2020 H1 Change FY2020 H1 reported reported

  • excl. IFRS

16 impact Net sales (million €) 595.4 727.2 +22.1% 727.2 Net sales growth at constant rates +19.0% Gross profit margin 82.4% 81.2%

  • 1.2 pp

81.2% Operating profit margin 1.0% 5.7% +4.7 pp 5.5% Net profit margin 0.9% 3.5% +2.6 pp 4.0% Earnings per share (€ per share) 0.005 0.017 +240.0% 0.020

slide-3
SLIDE 3

Accounting and comparability matters

3

Already in FY2020 H1 Cash / non-cash Recurring /

  • ne-off

Lease accounting under IFRS 16 Yes Non-cash Recurring ELEMIS acquisition costs through P&L Yes Cash One-off ELEMIS purchase price allocation No ELEMIS amortization of customer relationships No Non-cash Recurring Accounting treatment of fiscal depreciation of LimeLife and ELEMIS goodwills Yes (LL) No (Ele) Non-cash Recurring Swiss tax rate Yes Cash Recurring

slide-4
SLIDE 4

IFRS 16 Impact on Net Profit & Balance Sheet

* assumed the same effective tax rate percentage as in the reported profit for the period ended 30 September 2019. 4 FY2019 H1 FY2020 H1 FY2020 H1 Growth % Growth % reported reported IFRS 16 impacts excluding IFRS 16 impacts reported excluding IFRS 16 impacts € '000 € '000 € '000 € '000 Net Sales 595,385 727,157 727,157 22.1% 22.1% Cost of sales (104,857) (137,047) (137,047) Gross profit 490,528 590,110 590,110 20.3% 20.3% Operating profit 5,812 41,771 1,951 39,820 618.7% 585.1% Finance costs, net (1,687) (10,691) (6,843) (3,848) Foreign currency gains / (losses) (1,536) 1,618 (405) 2,023 Profit before income tax 2,589 32,698 (5,297) 37,995 1163.0% 1367.6% Income tax expense 2,999 (7,460) 1,208 (8,668)*

  • 348.7%
  • 389.0%

Net profit 5,588 25,238 (4,089) 29,327 351.6% 424.8% Total Assets (€ mil) 1,294 2,379 408 1,971 83.9% 52.4% Net (Cash) / Debt (€ mil) (164) 905 432 474

  • 650.7%
  • 388.1%
slide-5
SLIDE 5

6 151

20 40 60 80 100 120 140 160

FY2019 H1 FY2019

Operating profit (million €)

595 1,427

200 400 600 800 1,000 1,200 1,400 1,600

FY2019 H1 FY2019

Net Sales (million €)

42%

Seasonality: low profit contribution from 1H

5

4%

slide-6
SLIDE 6

L'Occitane en Provence 76.3% Elemis 11.6% LimeLife 5.6% Others 6.5%

H1 Net Sales Breakdown

By Business Segment By Geography By Brand

* Others include emerging brands Melvita, Erborian and L'Occitane au Brésil. *

Sell-

  • ut

66.1% Sell-in 33.9% USA 18.4% Japan 14.7% UK 10.6% China 10.5% Hong Kong 8.0% France 6.7% Brazil 3.6% Russia 3.1% Taiwan 2.1% Other countries 22.3% 6

slide-7
SLIDE 7

7 (1) Others include LimeLife, marketplaces and other service sales. (2) Excluding the impact of foreign currency translation effects.

H1 net sales up 19.0% at constant rates

(22.1% at reported rates)

50 100 150 200 250 300 350 400 Comp stores Non-comp stores & others Sell-in FX rates million € H1 FY2019 H1 FY2020 5% local currency growth: 19.0% currencies: 3.1% Contribution to growth (2) : 23% 73%

+2% +20% +52%

(1)

  • verall sales growth: 22.1%
slide-8
SLIDE 8

50 100 150 200 250 France UK USA Brazil Russia H1 FY2019 H1 FY2020 3% 48% 23% 2%

+7% +26%

3%

+10% +15%

Contribution to growth (1) :

+235%

million € 8 (1) Excluding foreign currency translation effects. (2) Excluding ELEMIS, growth in the UK was +10.8% at constant rates. (3) Excluding ELEMIS, growth in the US was -5.1% at constant rates.

H1 sales growth by geography – Americas and Europe

(at constant rates)

(2) (3)

slide-9
SLIDE 9

50 100 150 200 250 Japan Hong Kong China Taiwan Other geographic areas FX rates H1 FY2019 H1 FY2020 4%

  • 3%

8% 0% 13%

+4%

  • 6%

+13% +3% +10%

Contribution to growth (1) : million € 9

H1 sales growth by geography – Asia and others

(at constant rates)

(1) Excluding foreign currency translation effects.

slide-10
SLIDE 10

10 (1) Including own E-commerce

Same store sales growth profile (1)

H1 FY2020 compared to H1 FY2019

1.3% 5.4% 7.6%

  • 3.0%
  • 0.6%

2.0%

  • 0.3%
  • 19.0%

5.7% 1.9% 5.4% 1.7%

Japan Hong Kong China Taiwan Other geographic areas Group H1 FY2019 H1 FY2020

  • 4.6%
  • 0.8%

3.3% 6.4% 4.2%

6.7% 2.7%

  • 4.0%

1.0% 4.1%

France UK USA Brazil Russia

slide-11
SLIDE 11

Profitability analysis

11

% of net sales FY2019 H1 FY2020 H1 Change Gross profit margin 82.4 81.2 (1.2) Distribution expenses (55.0) (50.4) 4.6 Marketing expenses (14.6) (12.7) 1.9 Research & development expenses (1.4) (1.4) 0.0 General & administrative expenses (10.5) (10.9) (0.4) Other gains 0.1 0.0 (0.1) Operating profit margin 1.0 5.7 4.7

slide-12
SLIDE 12

Gross margin (as % of net sales)

12

82.4%

  • 1.7
  • 0.2
  • 0.1

+0.1 +0.1 +0.2 +0.4 81.2%

FY2019 H1 Brand mix promo tools new factory in Brazil &

  • thers

pricing product mix

  • bsole-

scence production & freight & duties FX FY2020 H1

slide-13
SLIDE 13

Distribution expenses (as % of net sales)

13

(55.0%)

  • 0.3
  • 0.1

+0.3 +0.3 +0.3 +0.5 +3.6 (50.4%)

FY2019 H1 LimeLife invest FX phasing &

  • thers

IFRS 16 Leverage & efficiency channel mix Brand mix FY2020 H1

slide-14
SLIDE 14

Marketing expenses (as % of net sales)

14

(14.6%)

  • 0.1

+0.3 +0.3 +0.6 +0.8 (12.7%)

FY2019 H1

  • ther

brand mix phasing leverage, efficiciency, teams advertising, events, tools, CRM FY2020 H1

slide-15
SLIDE 15

General & admin expenses (as % of net sales)

15

(10.5%)

  • 0.7
  • 0.3
  • 0.1

+0.1 +0.1 +0.5 (10.9%)

FY2019 H1 Acquisition costs Invest

  • ne-off &

litigations

  • thers

FX brand mix FY2020 H1

slide-16
SLIDE 16

Operating profit margin (as % of net sales)

16

1.0% +2.3 +1.4 +1.2 +0.5 +0.4 +0.4 +0.3

  • 0.9
  • 0.9

5.7%

FY2019 H1 brand mix leverage efficiency Targeted Controlled Marketing FX Phasing Channel mix IFRS 16 Acquisition fees & others Other invest FY2020 H1

slide-17
SLIDE 17

Working capital ratios

17

Inventory turnover days

302 +11 +13

  • 40

286

FY2019 H1 Existing brands FX ELEMIS FY2020 H1 as at: FY2019 H1 FY2020 H1 Change Inventory turnover days (based on cost of sales) 302 286

  • 16

Trade receivables turnover days (based on net sales) 33 38 5 Trade payables turnover days (based on cost of sales) 204 200

  • 4

Cash Cycle (days of net sales) 51 54 3

slide-18
SLIDE 18

(1) Net Operating Profit After Tax # / Capital Employed (2) Net profit attributable to equity owners / shareholders' equity excluding minority interest (3) Current assets / current liabilities (4) Current assets - stocks / current liabilities (5) Total debt / total assets (6) Net debt / (total assets - total liabilities) * 100%

#

NOPAT = (Operating Profit + foreign currency net gains or losses) x (1 - effective tax rate) Capital Employed = Non-current assets - (deferred tax liabilities + other financial liabilities + other non-current liabilities) + working capital

Balance sheet ratios

Reported

  • Excl. IFRS 16

impacts Reported FY2019 H1 FY2020 H1 FY2020 H1 Profitability Return on Capital Employed (ROCE)(1) 1.3% 2.1% 1.7% Return on equity (ROE)(2) 0.8% 2.9% 2.5% Liquidity Current ratio (times)(3) 2.6 1.5 1.2 Quick ratio (times)(4) 1.8 0.9 0.7 Capital adequacy Gearing ratio(5) 7.1% 25.9% 39.6% Debt to equity ratio(6) net cash position 44.0% 84.5%

18

slide-19
SLIDE 19

Capital expenditures

(excl. acquisitions of subsidiaries and financial investments)

19

22.4 8.0 13.0 1.7 45.0

17.8 8.8 12.1 0.0 38.7

stores Info. Tech. factories R&D

  • thers

Total million €

FY2019 H1 FY2020 H1

slide-20
SLIDE 20

20

Strategic review

Skincare Positioning Omni-channel Experiences Multi-brand Strategy Targeted Investments Engaging Marketing Campaigns Sustainability

  • Immortelle Reset serum on

track to sell 1 million units for the full year

  • ELEMIS will further bolster

the skincare segment

  • Further diversification of

brand mix is expected

  • ELEMIS’ market expansion is

imminent

  • Each brand encouraged to

be autonomous while identifying synergies

  • Leveraged expertise of local

marketing teams to create culturally-relevant and impactful campaigns

  • Successful “Balloon Journey”

brand event held for a second year to an expanded number of cities

  • Aim to provide a seamless

path-to-purchase online and

  • ffline
  • Created exciting retail

experiences in key cities such as Tokyo and London

  • Focus on profitability

evident in disciplined and targeted investments

  • Marketing investments are

concentrated on major campaigns, products and channels

  • Sustainability is prioritized at

every step of the value chain

  • Expanded agreement with

Loop Industries to transition to 100% sustainable PET plastic packaging earlier than expected

slide-21
SLIDE 21

21

Outlook

“Pulse” Strategy Multi-brand Group Holiday Season

  • Continue to execute the

“Pulse” strategy to build trust, achieve sustainable growth and enhance profitability

  • Expect to see enhanced

profitability with targeted investments and the consolidation of the ELEMIS brand

  • Operate as multi-brand

group where unique brand identities are celebrated and common values shared

  • Brands stay autonomous

and agile while seeking synergies

  • Upcoming holiday season

remains a key period

  • Strong marketing calendar

and targeted investments should further energize the Group’s profitability drive

The Group remains confident to pursue its mission to be a leader in the affordable premium beauty space and deliver long-term value to its shareholders

slide-22
SLIDE 22

22

This document is for information purposes only without any binding effect; in case

  • f any inaccuracies, incompleteness or inconsistency with other documents, only

the Company’s latest issued annual or interim report for detailed financials shall prevail and shall be deemed to be the only official document. The financial information and certain other information presented in a number of tables have been rounded to the nearest whole number or the nearest decimal. Therefore, the sum of the numbers in a column may not conform exactly to the total figure given for that column. In addition, certain percentages presented in the tables reflect calculations based upon the underlying information prior to rounding and, accordingly, may not conform exactly to the percentages that would be derived if the relevant calculations were based upon the rounded numbers.

Disclaimer

slide-23
SLIDE 23